Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-104906
Filing Date
2024-09-10
Accepted
2024-09-10 06:06:09
Documents
4
Period of Report
2024-09-10

Document Format Files

Seq Description Document Type Size
1 6-K opt_announces_euretina.htm 6-K 23372
2 PRESS RELEASE opt-ex99_1.htm EX-99.1 34289
3 GRAPHIC img260626642_0.jpg GRAPHIC 62433
4 GRAPHIC img260626642_1.jpg GRAPHIC 62433
  Complete submission text file 0000950170-24-104906.txt   230715
Mailing Address LEVEL 4 650 CHAPEL STREET SOUTH YARRA, VICTORIA C3 3141
Business Address LEVEL 4 650 CHAPEL STREET SOUTH YARRA, VICTORIA C3 3141 61 3 9826 0399
Opthea Ltd (Filer) CIK: 0001815620 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-39621 | Film No.: 241288687
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)